1. Buyer
1.1.
Buyer
Official name: European Union Drugs Agency
Legal type of the buyer: EU institution, body or agency
Activity of the contracting authority: General public services
2. Procedure
2.1.
Procedure
Title: Framework contract for EUDA scientific studies support services
Description: The purpose of this procurement procedure is to purchase capacity to support the Agency in the preparation of high-quality scientific services and overall to increase the Agency’s timeliness, anticipatory and responsive capacity. The Agency requires access to supporting specialised expertise in the design, conduct, and reporting of different types of scientific work. Outputs may include reports, digital dashboards, AI based tools, methodological and reporting guidelines, training materials, workshops, databases, collection of literature, etc. The present procurement procedure is aimed at supporting the Agency to rapidly mobilise external expertise in a flexible and efficient manner, ensuring responsiveness to evolving scientific priorities and emerging evidence needs. The activities resulting from this procedure are expected to support the EUDA in monitoring drug markets, use of substances and their consequences. They will also help identify the evidence needed to inform responses in terms of establishing trends, examining emerging threats and tracking developments over time and between settings. Ultimately, this is expected to strengthen the preparedness of the Agency, and of the EU as a whole, to respond to drug-related harms.
Procedure identifier: 80498c1a-0711-485b-bb4b-2ac0a2f4e003
Internal identifier: EUDA/2026/OP/0006
Type of procedure: Open
The procedure is accelerated: no
2.1.1.
Purpose
Main nature of the contract: Services
Main classification (cpv): 73000000 Research and development services and related consultancy services
2.1.2.
Place of performance
Anywhere
Additional information: Please consult the procurement documents.
2.1.3.
Value
Estimated value excluding VAT: 8 000 000,00 EUR
2.1.4.
General information
Additional information: In case of unavailability or disruptions in the functioning of the electronic means of communication provided in Section 5.1.11 in the last 5 calendar days before the time limit for receipt indicated in Section 5.1.12, the contracting authority reserves the right to extend this time limit and publish the extension at the Internet address provided in Section 5.1.11, without a preceding publication of a corrigendum to this notice. Economic operators interested in this procurement are invited to subscribe to the call for tenders at the address in Section 5.1.11 in order to get notified when new information or documents are published.
Legal basis:
Regulation (EU, Euratom) 2024/2509
2.1.6.
Grounds for exclusion
Sources of grounds for exclusion: Procurement Document
5. Lot
5.1.
Lot: LOT-0001
Title: Framework contract for EUDA scientific studies support services
Description: The purpose of this procurement procedure is to purchase capacity to support the Agency in the preparation of high-quality scientific services and overall to increase the Agency’s timeliness, anticipatory and responsive capacity. The Agency requires access to supporting specialised expertise in the design, conduct, and reporting of different types of scientific work. Outputs may include reports, digital dashboards, AI based tools, methodological and reporting guidelines, training materials, workshops, databases, collection of literature, etc. The present procurement procedure is aimed at supporting the Agency to rapidly mobilise external expertise in a flexible and efficient manner, ensuring responsiveness to evolving scientific priorities and emerging evidence needs. The activities resulting from this procedure are expected to support the EUDA in monitoring drug markets, use of substances and their consequences. They will also help identify the evidence needed to inform responses in terms of establishing trends, examining emerging threats and tracking developments over time and between settings. Ultimately, this is expected to strengthen the preparedness of the Agency, and of the EU as a whole, to respond to drug-related harms.
Internal identifier: EUDA/2026/OP/0006
5.1.1.
Purpose
Main nature of the contract: Services
Main classification (cpv): 73000000 Research and development services and related consultancy services
5.1.2.
Place of performance
Anywhere
Additional information: Please consult the procurement documents.
5.1.3.
Estimated duration
Duration: 48 Months
5.1.5.
Value
Estimated value excluding VAT: 8 000 000,00 EUR
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project fully or partially financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Quality
Description: Please consult the procurement documents.
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 70
Criterion:
Type: Price
Description: Please consult the procurement documents.
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 30
5.1.11.
Procurement documents
Deadline for requesting additional information: 23/11/2026 23:59:59 (UTC+00:00) Western European Time, GMT
Ad hoc communication channel:
Name: Funding and Tenders Portal
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Bulgarian, Czech, Danish, German, Greek, English, Spanish, Estonian, Finnish, French, Irish, Croatian, Hungarian, Italian, Lithuanian, Latvian, Maltese, Dutch, Polish, Portuguese, Romanian, Slovak, Slovenian, Swedish
Electronic catalogue: Not allowed
Deadline for receipt of tenders: 02/12/2026 12:00:59 (UTC+00:00) Western European Time, GMT
Duration during which the tender must remain valid: 9 Months
Information about public opening:
Opening date: 03/12/2026 10:30:00 (UTC+00:00) Western European Time, GMT
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Allowed
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 3
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Court of Justice of the European Union
Organisation providing more information on the review procedures: European Union Drugs Agency
8. Organisations
8.1.
ORG-0001
Official name: European Union Drugs Agency
Registration number: EUDA
Department: EUDA.ED - Executive Director,EUDA.ED.EXO - Executive office
Postal address: Praça Europa 1, Cais do Sodré
Town: Lisbon
Postcode: P-1249-289
Country subdivision (NUTS): Grande Lisboa (PT1A0)
Country: Portugal
Telephone: +351 21 121 02 00
Roles of this organisation:
Buyer
Organisation providing more information on the review procedures
8.1.
ORG-0002
Official name: Court of Justice of the European Union
Registration number: CURIA
Postal address: Rue du Fort Niedergrünewald
Town: Luxembourg
Postcode: L-2925
Country subdivision (NUTS): Luxembourg (LU000)
Country: Luxembourg
Telephone: +352 4303-1
Roles of this organisation:
Review organisation
8.1.
ORG-0003
Official name: European Commission
Registration number: EUCOM
Postal address: Mondrian (CDMA), Rue du Champ de Mars 21
Town: Brussels
Postcode: B-1050
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
Telephone: +32 2 299 11 11
Roles of this organisation:
TED eSender
10. Change
Notice identifier/version: 4e7900e9-6654-44b4-b4ec-63645883565f - 01
Form type: Competition
Notice type: Contract or concession notice – standard regime
Notice subtype: 16
Notice dispatch date: 14/10/2026 20:38:08 (UTC+02:00) Eastern European Time, Central European Summer Time
Languages in which this notice is officially available: English
Notice publication number: 717056-2026
OJ S issue number: 201/2026
Publication date: 16/10/2026